Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydroxychloroquine in Acute Coronary Syndrome: Prevention of Recurrent Cardiovascular Events
2015-000233-73Phase 2Completed
- Sponsor
- Helsinki University Hospital
- Start
- Nov 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of hydroxychloroquine in acute coronary syndrome (ACS) and cardiac morbidity, sponsored by Helsinki University Hospital. Primary endpoint: Major coronary complication rate at 6 months. Started Nov 2015; status: completed.
02
Drugs
hydroxychloroquine
03
Conditions
acute coronary syndrome (ACS)cardiac morbidity
Beyond the preview
Go deeper on 2015-000233-73.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-000233-73.